Overview

The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects

Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
To assess the effects of 3 blood pressure drugs, called angiotensin receptor blockers, on the blood pressure control systems in healthy subjects.
Phase:
Phase 4
Details
Lead Sponsor:
Daiichi Sankyo Inc.
Daiichi Sankyo, Inc.
Treatments:
Irbesartan
Olmesartan
Olmesartan Medoxomil
Valsartan